Note: Ingredients listed on restricted chemical lists
EC/CAS
201-173-7/79-06-1
Name of the chemical
Acrylamide
Concentration
<100
General Information
Version
2019
Revision date
2019-07-04
Product name
Acrylamide
CAS No.
79-06-1
1.2.1 Relevant identified uses
For Laboratory Research Use Only
1.2.2. Uses advised against
Not for Human or Animal Drug Use
supplier name
Bio Basic Inc
Icons in SDS
Company Information
company name
Bio Basic Inc
e-mail address of the competent person responsible for the Safety Data Sheet
order@biobasic.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H312, H312+H332, H315, H317, H319, H332, H340, H350, H361, H372, H402
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
- - - - GHS Classification Classification of the substance or mixture GHS Classification in accordance with Hazardous Products Regulations (HPR) (SOR/2015-17) Acute toxicity, Oral (Category 3), H301 Acute toxicity, Inhalation (Category 4), H332 Acute toxicity, Dermal (Category 4), H312 Skin irritation (Category 2), H315 Eye irritation (Category 2A), H319 Skin sensitisation (Category 1), H317 Germ cell mutagenicity (Category 1B), H340 Carcinogenicity (Category 1B), H350 Reproductive toxicity (Category 2), H361 Specific target organ toxicity - repeated exposure, Oral (Category 1), Peripheral nervous system, H372 Acute aquatic toxicity (Category 3), H402 For the full text of the H-Statements mentioned in this Section, see Section 16
Signal word
Danger
Hazard statements
H301 Toxic if swallowed. H312 + H332 Harmful in contact with skin or if inhaled. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H340 May cause genetic defects. H350 May cause cancer. H361 Suspected of damaging fertility or the unborn child. H372 Causes damage to organs (Peripheral nervous system) through prolonged or repeated exposure if swallowed. H402 Harmful to aquatic life.
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/ fume/ gas/ mist/ vapours/ spray. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P271 Use only outdoors or in a well-ventilated area. P272 Contaminated work clothing should not be allowed out of the workplace. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P301 + P310 + P330 IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/doctor if you feel unwell. P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P337 + P313 If eye irritation persists: Get medical advice/ attention. P362 + P364 Take off contaminated clothing and wash it before reuse. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.
2.3 Other hazards
- none
2.1 Classification of the substance or mixture
GHS Classification in accordance with Hazardous Products Regulations (HPR) (SOR/2015-17) Acute toxicity, Oral (Category 3), H301 Acute toxicity, Inhalation (Category 4), H332 Acute toxicity, Dermal (Category 4), H312 Skin irritation (Category 2), H315 Eye irritation (Category 2A), H319 Skin sensitisation (Category 1), H317 Germ cell mutagenicity (Category 1B), H340 Carcinogenicity (Category 1B), H350 Reproductive toxicity (Category 2), H361 Specific target organ toxicity - repeated exposure, Oral (Category 1), Peripheral nervous system, H372 Acute aquatic toxicity (Category 3), H402 For the full text of the H-Statements mentioned in this Section, see Section 16.